Pharmaceutical

Moderna’s mRNA influenza vaccine receives $176m boost

Moderna has received a grant of $176m through the RRPV Consortium to expedite the development of mRNA-based pandemic influenza vaccines.

Jul 4, 2024 - 04:00
Moderna’s mRNA influenza vaccine receives $176m boost
Moderna has received a grant of $176m through the RRPV Consortium to expedite the development of mRNA-based pandemic influenza vaccines.
Read the original article

Tags:

Previous Article

Johnson & Johnson gains FDA and EC approvals for TB treatment

Next Article

Left in limbo: When pharma halts rare disease research

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Biden nominates Monica Bertagnolli to head NIH

Biden nominates Monica Bertagnolli to head NIH

May 15, 2023

STAT+: A yogurt drink instead of a colonoscopy? Study uses engineered bacteria to detect cancer

STAT+: A yogurt drink instead of a colonoscopy? Study u...

Aug 11, 2023

SBTi approves Piramal Pharma’s GHG reduction targets

SBTi approves Piramal Pharma’s GHG reduction targets

Sep 18, 2024